(Q77988774)
Statements
Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis (English)
D E Goodkin
S Reingold
W Sibley
J Wolinsky
H McFarland
D Cookfair